Oslo, Norway

Anita Kavlie

USPTO Granted Patents = 20 


 

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 170(Granted Patents)


Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents

Title: The Innovative Journey of Anita Kavlie: A Pioneer in Complement Activation Research

Introduction: Anita Kavlie, an accomplished inventor based in Oslo, Norway, has made significant contributions to the field of biomedical research. With a remarkable portfolio of 20 patents, she stands out as a leading innovator, particularly in the area of complement activation. Her groundbreaking work is aimed at improving various therapeutic strategies, showcasing her dedication to advancing medical science.

Latest Patents: Among Kavlie's most recent patents are the compositions for inhibiting MASP-2 dependent complement activation. This invention pertains to anti-MASP-2 inhibitory antibodies and compositions comprising such antibodies, which are designed to mitigate the adverse effects associated with MASP-2 dependent complement activation. Through her innovative approach, Kavlie is paving the way for new treatment options in immunology.

Career Highlights: Throughout her career, Anita Kavlie has worked with notable organizations, expanding her expertise and influence in her field. She has contributed her skills at Hoffmann-La Roche Inc. and Affitech Research AS, where her research has facilitated advancements in therapeutic developments. Her passion for innovation is evident in her commitment to creating solutions that address complex medical challenges.

Collaborations: Collaboration has played a vital role in Kavlie's inventive journey. She has worked alongside talented individuals, including Christian Klein and Ulrich Brinkmann. These partnerships have fostered an environment of creativity and collaboration, leading to innovative outcomes that enhance the landscape of biomedical research.

Conclusion: Anita Kavlie's contributions to the field of complement activation research are remarkable. Her extensive patent portfolio reflects her dedication to innovation and her desire to improve healthcare outcomes. Through her work, Kavlie continues to inspire future generations of inventors and scientists, proving that innovative thinking and collaboration can lead to significant advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…